Sales of $479 million, down 17 percent from the prior-year quarterPreviously announced carboxymethylcellulose (CMC), methylcellulose (MC), nutraceuticals and Avoca portfolio optimization initiatives ...

Despite lower-than-expected first-quarter revenues and a guidance cut for 2025, NVO stock price rose post its earnings ...

Novo Nordisk NVO and Jazz Pharmaceuticals JAZZ reported their first-quarter results. AstraZeneca’s AZN late-stage asthma ...

Novo Nordisk is hedging and building its way around a global tariff war that may threaten the Wegovy maker’s plans to expand ...

Skye Bioscience Inc (SKYE) reports significant advancements in clinical trials and a strong financial position, despite ...

The insurance business is shaky but care delivery subsidiaries such as Optum, Evernorth Health Services, CenterWell and ...

Volatility in the economy is causing digital health companies to rethink their strategies for the remainder of 2025.

Novavax posts $667 million in Q1 2025 revenue and $2.93 EPS, boosted by Sanofi payments and APA terminations; full-year ...

GoodRx Holdings, Inc. ( NASDAQ: GDRX) Q1 2025 Earnings Conference Call May 8, 2025 8:00 AM ET Aubrey Reynolds – Director-Investor Relations Wendy Barnes – President and Chief Executive Officer Chris ...

May 7, 2025Marqeta, Inc. beats earnings expectations. Reported EPS is $-0.02, expectations were $-0.03. Operator: Ladies and ...

Shares rallied Wednesday even after the drugmaker lowered its full-year guidance as alternative versions of its blockbuster ...

Sales are booming for Lilly's tirzepatide products, Mounjaro and Zepbound. The company's market share for incretin analogs ...